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Non-Syncytium-Inducing HIV Type 1 Isolated from Infected
Individuals Replicates in MT-2 Cells
SERENE E. FORTE, KEVIN S. BYRON, JOHN L. SULLIVAN, and MOHAN SOMASUNDARAN
ABSTRACT
Human immunodeficiency virus type 1 (HIV-1) isolates from six infected individuals less then 4 years of age
were phenotyped for their syncytium-inducing (SI) ability in MT-2 cells. Three viral isolates that induced syn-
cytia were detected. One SI isolate was from an individual who was in disease stage P2A,B,C and two SI iso-
lates were recovered sequentially from another individual who switched from disease stage P1B to P2F. Non-
syncytium-inducing (NSI) isolates were detected in two individuals who were in stage P1B of disease, and in a
third individual who was in stage P2A of disease. Three sequential isolates obtained over a 2-year period from
a fourth individual who progressed from disease stage P1B to P2A,B,C and subsequently died of AIDS-related
disease were also found to have the NSI phenotype. To test whether NSI isolates can replicate in the absence of
syncytium formation, we analyzed NSI -infected MT-2 cells for production of viral p24 antigen and expression
of viral RNA by in situ hybridization. By day 12 postinfection, 6 of 7 NSI viral isolates produced 7- to 36-fold
increases in p24 antigen compared to day 6, and expressed viral RNA in 13-20% of cells. A single NSI isolate
that did not replicate in MT-2 cells was obtained from an individual who was asymptomatic (stage P1B). The
individual rapidly progressed to symptomatic stage P2F and two sequential SI viruses were isolated. These SI
isolates replicated in MT-2 cells and induced cytopathic effects. These results suggest that some cytopathic vi-
ral isolates replicate in MT-2 cells in the absence of syncytium induction and replication in MT-2 cells may
serve as an indicator for disease progression in certain HIV-infected individuals.
INTRODUCTION symptomatic disease state.8-1112 Thus, earlier in infection the
predominant species of virus is noncytopathic and nonsyn-
THE mechanism of PATHOGENESis underlying progression to cytium inducing (NSI). With the onset of AIDS, viral isolatesAIDS in HTV-1-infected individuals is largely unknown. It are cytopathic and SI. The emergence of SI variants also cor-
is, however, well documented that steady depletion of CD4 T relates with immunological and clinical deterioration of in-
cells is associated with progressive immunodeficiency.1 fected individuals, progressing toward full-blown AIDS.13-14
Although CD4 T cell counts serve as markers for disease pro- Therefore, along with CD4 T cell counts, the appearance of the
gression,2-3 the mechanisms of CD4 T cell depletion have yet to SI phenotype has been used as a marker for disease progres-
be identified. Syncytium formation, single-cell death following sion.11
high viral load, and apoptosis are a few of the many mecha- A highly permissive T cell line (MT-2 cells) that is suscepti-
nisms proposed for CD4 T cell lysis.4-6 Studies investigating ble to syncytium formation is used to differentiate NSI vs. SI
the course of HIV-1 infection in seropositive individuals clearly phenotypes in vitro.9 Further analyses of HIV-1 and MT-2 cell
suggest that a progressive increase in viral load correlates with interactions reveal that syncytia in MT-2 cells are a product of
emergence of AIDS.7 Remarkably, during this period, there are viral replication and that NSI phenotypes do not infect and/or
major changes in the biological phenotype of viral isolates.8-9 replicate in MT-2 cells.15-16
One of the prominent characteristics of viruses isolated dur- We are investigating mechanisms of HIV-induced cyto-
ing the latter stages of AIDS is their cytopathic phenotype.10 pathicity and CD4 T cell depletion. To this end, adult and pedi-
The syncytium-inducing (SI) ability of viral isolates in suscep- atric viral isolates have been phenotyped with regard to their
tible cells also changes with the switch from asymptomatic to syncytium-inducing ability in MT-2 cells. Unexpectedly, we
Department of Pediatrics, Program in Molecular Medicine, University of Massachusetts Medical School, 373 Plantation Street, Worcester,
Massachusetts 01605.
1613
1614 FORTE ET AL.
observed that NSI viral isolates from four of five pédiatrie pa-
tients replicated to high titer in MT-2 cells, as measured by p24
antigen production and in situ viral RNA expression. One in-
fected individual died of AIDS at 18 months of age following a
dramatic decline in CD4 T cell counts. Three sequential isolates
from this individual (obtained at 2, 6, and 18 months of age)
replicated in MT-2 cells; yet none of these viral isolates (presum-
ably cytopathic in vivo) induced syncytia in MT-2 cells. We re-
port here that the ability of viral isolates to replicate in MT-2 cells
does not always correlate with their respective NSI or SI pheno-
type. Viral isolates recovered from HIV-1-infected infants with
near-normal or low CD4 T cell counts replicated in MT-2 cells
regardless of phenotype. In summary, we have shown that HTV-1
isolates replicate in MT-2 cells in the absence of syncytium in-
duction and that progressive immune deficiency occurs in vivo in
patients who do not have SI viral isolates.
MATERIALS AND METHODS
Patients
Six HIV-1-positive pédiatrie patients less than 4 years of age
were studied with respect to biological phenotype of their viral
isolates. Absolute CD4 T cell counts of these children ranged
from 64 to 3015s/mm3. Clinical stages of the disease for each
individual are presented in Table 1.
Isolation and titration of virus
Virus from each infected individual was isolated by cocul-
ture with phytohemagglutinin (PHA)-stimulated normal
seronegative donor peripheral blood lymphocytes (PBLs) ac-
cording to the AIDS Clinical Trial Group (ACTG) Virology
Reference Laboratory (VRL) protocol17. Patient viral isolates
were titered by limiting dilution on PHA-stimulated normal
seronegative donor PBLs.18 The titers of individual viral iso-
lates are presented in Table 1.
MT-2 cells
MT-2 cells are human T cell leukemia cells. These were ob-
tained from the AIDS Research and Reference Reagent
Program (Cat. No. 237; Bethesda, MD) and propagated in
RPMI 1640 containing 10% fetal bovine serum.
Detection of syncytium-inducing HIV-1 isolates
Syncytium-inducing HIV-1 isolates were detected using the
standardized protocol formulated by the ACTG Virology
Committee.8-9-19 Titered stocks of patient viral isolates (50 pi)
were used to infect quadruplicate microcultures of MT-2 cells(5 x 104) in wells of 96-well tissue culture plates containing a
200-pl final volume. Positive controls were set up using titered
laboratory stocks of HIV-1 (50% tissue culture infective dose
[TCID50]/50 pi = 32,750). Negative controls were either un-
amended medium, or culture supernatant containing a pol-de-
fective, noninfectious NL4-3 HIV-1 strain derived from the
8E5 cell line.20 Plates were incubated at 37°C (5% C02). Every
third day the wells were examined for syncytia, the cell suspen-
sion in each well mixed, and 130 pi of the cell suspension dis-
carded and replaced with 150 pi of fresh medium. On day 14
the assay was terminated and the phenotype of each viral stock
was recorded. If three to five "balloons" or giant cells were de-
tected per well under high-power field, the cell culture was
scored as positive for syncytia and the phenotype of the viral
isolate was recorded as SI. A viral isolate that did not induce
syncytia in MT-2 cell culture was phenotyped as NSI. In case of
discordant results among quadruplicate wells of a viral stock,
the assay was repeated for that particular virus.
Determination of viral replication: Enzyme-linked
immunosorbent assay (ELISA) to detect
HIV-1 p24*a* protein
To follow viral replication in MT-2 cells, cell-free culture
supernatants taken every third day at the time of medium ex-
Table 1. Age, Disease Stage, CD4 T Cell Counts of HTV-1-Infected Patients, and Syncytium-Inducing and
Replication Abilities of Viral Isolates from These Individuals
Patient
Age(months) Stageof disease*
CD4
count/mm3
Viral
isolate
Titer
(TCIDsc/50 pi)
MT-2
phenotype
p24 (ng/ml)
HTV-1 RNA
positive(by 1SH)
Day 6 Day 12 Day 6 Day 14
A
B
C
D
E
47
13
1
7
36
48
2
6
18
3
10
12
P1B
P2A
P1B
P1B
P2A,C
P2A,B,C
P1B
PIA
P2A,B,C
P1B
P2F
P2F
2,312
2,242
2,091
2,541
64
8
3,015
1,231
171
1,370
1,826
2,402
A
B
Cl
C2
Dl
D2
El
E2
E3
Fl
F2
F3
2,050
20,600
32,750
32,750
20,620
30
128
510
51
320
5,160
5,160
NSI
NSI
NSI
NSI
SI
SI
NSI
NSI
NSI
NSI
SI
SI
7.5
8.4
ND
5.8
44.8
29.8
2.2
10.9
4.3
109.6
133.9
125.4
61.5
166.3
195.0
57.2
2,029
2,042
14.3
364.7
41.0
6.8
348.0
217.9
5
ND
6
ND
97
ND
ND
9
ND
ND
ND
ND
20
ND
ND
ND
70
ND
ND
20
ND
ND
ND
ND
"Classification of HTV-1 infection in children under 13 years of age as described by Centers for Disease Control (Atlanta, GA).
Abbreviations: ISH, in situ hybridization; SI, syncytium-inducing; NSI, nonsyncytium inducing; ND, not done.
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change from each of quadruplicate wells were assayed for
HIV-1 p24fr<IS protein using an antigen capture ELISA (Coulter
Immunology, Hialeah, FL) according to manufacturer instruc-
tions. In our assay, culture supernatants were considered to be
positive for HIV-1 when the levels of p24 protein were >30
pg/ml. Steady increases in cell-free p24 protein levels with time
indicated active viral replication in cells.
Determination of viral replication: In situ
hybridization to detect HIV-1 RNA in MT-2 cells
A sample of infected cells was washed with phosphate-
buffered saline (PBS), air dried on microscope slides, and fixed
in 4% paraformaldehyde for 10 min at room temperature. The
slides were rinsed in PBS and stored at 4°C in 70% ethanol. At
the time of assay, cells were rehydrated and HIV-1 RNA was
detected by in situ hybridization according to a previously de-
scribed method.21 A nick-translated, biotin-labeled full-length(8.9-kb) pHXB-2 HIV-1 DNA specific for HTV-1 genomic or
mRNA transcripts was used as the probe. Avidin-labeled alka-
line phosphatase was used as the marker to detect the biotiny-
lated probe.21
RESULTS
Phenotypes of pédiatrie viral isolates from seropositive indi-
viduals were determined from syncytial assays on MT-2 cells.
The positive and negative controls in the MT-2 syncytial assays
were normal in all assays. Table 1 describes clinical status,
CD4 T cell counts, and SI/NSI phenotype of viral isolates and
their corresponding titers from each patient.
Patient isolate Cl did not induce syncytia in MT-2 cells and
was therefore phenotyped as NSI (Table 1); as was a second iso-
late C2 from the same individual 6 months later (Table 1). During
this period, the individual remained clinically asymptomatic
(P1B) and the CD4 T cell counts of this individual did not change
dramatically (2091 and 2541; Table 1). Viral isolates from pa-
tients A and B had an NSI phenotype (Fig. IB). Clinically, these
patients were classified as P1B (mild) and P2A (mild) and their
CD4 T cell counts were 2312 and 2242 (Table 1).
Viral isolates Dl and D2, derived 1 year apart from patient
D, both induced syncytia in MT-2 cells and were, therefore, de-
termined as SI (Fig. 1C, Table 1). Patient D was clinically clas-
sified as P2A.C (mild) with a CD4 T cell count of 64/mm3 and
1 year later had progressed clinically to stage P2A,B,C (severe),
with a CD4 T cell count of 8 (Table 1).
Sequential viral isolates were obtained from patient E over a
16-month period. The first isolate, El, did not induce syncytia(NSI) and was obtained when the individual was asymptomatic
(stage P1B) with a CD4 T cell count of 3015. Within the fol-
lowing year, the patient progressed rapidly to stage P2A,B,C
and the CD4 T cell count had dropped to 171. During this pe-
riod two viral isolates (E2 and E3) remained NSI (Table 1).
Although the viral isolate remained NSI, the patient died a few
months later.
To determine whether the SI/NSI phenotype of viral isolates
correlated with their ability to infect and/or replicate in MT-2
cells, we assayed for the production of HIV-1 p24sa* protein
and expression of viral RNA. By day 6 of MT-2 syncytial as-
says, high levels of HIV-1 p24 were detected in the cell-free su-
pernatants of cultures infected with NSI isolates from patients
A, C (isolate Cl), and E (isolate E2). The levels of p24 steadily
increased and by day 12 the culture supernatants were deter-
mined to contain 7- to 36-fold higher levels of HIV-1 p24«°s
protein (Table 1). Increasing levels of HIV-1 p24 (50- to
75-fold) were also found in cultures infected with SI isolates
from patient D (isolates Dl and D2; Table 1).
To confirm active viral replication in MT-2 cells infected
with NSI isolates from patients A and E (isolate E2), HIV-1
RNA expression was determined by in situ hybridization (ISH).
Viral RNA was detected in MT-2 cells infected with viral iso-
lates from patients A and E (isolate E2; Fig. 2B-E). In cultures
of MT-2 cells infected with the NSI isolate of patient A, cells
staining positive for HIV-1 RNA increased from 2% (day 3) to
5% (day 6). By day 14, when the MT-2 syncytial assay was ter-
minated, 20% of the cells were positive for HIV-1 RNA by ISH
(Table 1). Similarly, 9% of MT-2 cells infected with an NSI
isolate from patient E (isolate E2) were positive for viral ex-
pression; by day 14, 20% of the cells were positive for viral
RNA (Table 1). The number of cells expressing HIV-1 RNA in
cultures of MT-2 cells infected with the SI isolate of patient D
FIG. 1. Phenotype (NSI/SI) of viral isolates from HIV-1-
infected patients: The NSI/SI phenotype of viral isolates was
determined by a syncytial assay using MT-2 cells.8-9-19 Shown
here is a representative field from cultures of MT-2 cells alone(A), and MT-2 cells infected with an NSI isolate from patient A(B) or an SI isolate, D2, from patient D (C).
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FIG. 2. Detection of HIV-1 RNA-expressing MT-2 cells in-
fected with NSI or SI viral isolates from infected individuals:
MT-2 cells were infected with patient HIV-1 isolates. Viral
RNA was detected by in situ hybridization using a biotinylated,
nick-translated whole HIV-1 DNA genome as probe.21
Uninfected MT-2 cells (A); cells infected with NSI isolate from
patient A, day 3 (B) and day 6 (C); cells infected with NSI iso-
late, E2, from patient E, day 3 (D) and day 6 (E); cells infected
with SI isolate, D2, from patient D, day 3 (F) and day 6 (G).
(isolate Dl) ranged from 12% on day 3 to >90% by day 6
(Table 1, and Fig. 2F and G).
The variation in phenotypic pattern of viral isolates from pa-
tient F was similar to that reported for adult patients.15 At the
early asymptomatic stage of disease (P1B) the phenotype of the
viral isolate was NSI. Within a period of 12 months, two se-
quential isolates derived from patient F showed SI phenotypes.
The individual progressed from asymptomatic stage P1B to
symptomatic stage P2F during this period but a dramatic de-
cline in CD4 T cell count was not observed. Levels of viral p24
production in MT-2 cells infected with either of the two SI iso-
lates (F2 and F3) increased whereas p24 levels did not increase
in cells infected with the NSI isolate (Fl ; Table 1).
The syncytium-inducing ability of patient viral isolates in
MT-2 cells was not dependent on the amount of viral inoculum(Table 1). Patient isolates with relatively high titer (e.g., iso-
lates Cl and C2) were NSI and did not induce syncytia in
MT-2 cells. Viral isolates B and Dl had similar inoculum titers
(TCID50/50 pi = -20,600) but showed opposite phenotypes in
MT-2 cells: isolate B was NSI and isolate Dl was SI. Viral iso-
late D2 was SI in MT-2 cells. However, viral isolate A was NSI
even though the initial inoculum of isolate A was >64 fold
higher in titer than that of isolate D2. The replicative ability of
viral isolates in MT-2 cells was also independent of the inocu-
lum titer. Syncytium-inducing viral isolates F2 and F3 repli-
cated two- to threefold in MT-2 cells between days 6 and 12 of
infection. Each of these isolates had an initial titer of 5160
TCID50/50 pi. However, NSI isolates E2 (TCID50/50 pi = 510)
and E3 (TCID50/50 pi = 51) with lower titers than SI isolates
replicated 30- and 10-fold, respectively, in MT-2 cells between
days 6 and 12 of infection.
DISCUSSION
In this article we have determined the phenotype of pédiatrie
HIV-1 isolates with respect to their ability to induce syncytia in
MT-2 cell cultures. Earlier reports have suggested that SI
viruses can productively replicate in MT-2 cells whereas NSI
viral isolates cannot.8-9-22 Contrary to these reports, we have ob-
served that pédiatrie patient isolates with the NSI phenotype
readily infect and replicate in MT-2 cells. A steady increase in
the levels of HIV-1 p24sa-s protein was observed in cultures of
MT-2 cells infected with NSI isolates from patients A, B, C,
and E. The levels of p24 in these cultures varied from 7- to
36-fold higher than the input levels. By comparison, cultures
infected with SI viral isolates contained levels of p24 approxi-
mately 60-fold higher than the inoculum. This suggested that
p24 protein detected in the culture supernatants of MT-2 cells
infected with NSI or SI isolates was not derived from the initial
inoculum but resulted from active viral replication in MT-2
cells. In addition to the detection of HIV-1 p24gag protein levels,
we used in situ hybridization to detect active replication in
MT-2 cells. The percentage of MT-2 cells expressing HIV-1
RNA in cultures infected with SI or NSI isolates increased from
undetectable to >90% and >20%, respectively. These data con-
firm that, like SI isolates, NSI isolates can productively repli-
cate in MT-2 cells.
We have also observed that the ability to replicate in MT-2
cells and to induce syncytia was independent of the titer of the
initial viral inoculum. We have identified pédiatrie viral isolates
that replicate in MT-2 cells in the absence of syncytium forma-
tion despite their titer being 103-fold higher than a replicating,
SI isolate. Furthermore, NSI isolates retained their phenotype
when MT-2 cells were either infected with 20-fold more of the
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NSI viral inoculum or the infected cells were maintained for 28
days, twice the time period the ACTG protocol19 called for(data not shown).
Of further interest to us were the cytopathic properties asso-
ciated with NSI and SI phenotypes. It has been proposed that
syncytium formation plays a major role in in vivo CD4 T cell
depletion and HIV cytopathicity.4 The NSI phenotype has been
associated with lack of clinical progression in seropositive,
asymptomatic individuals who have relatively healthy immune
systems and high CD4 counts. During the latter stages of dis-
ease, when CD4 counts dramatically drop and the immune sys-
tem deteriorates, SI strains become the predominant phenotype
in vivo.10 This has led to the hypothesis that SI variants are rel-
atively more cytopathic than NSI variants because of their abil-
ity to induce syncytia.8 In our study, the SI isolates Dl and D2
from patient D were cytopathic to MT-2 cells. This correlates
with a progression to a severe stage of disease in this patient.
Patient E was a child whose disease stage progressed during
the study and died of AIDS with CD4 T cell counts dropping
dramatically from 3015 to 171. This suggests that the patient's
virus was cytopathic in vivo. However, all isolates of patient E
were NSI in phenotype. Taken together, this suggests that the
syncytium-inducing ability of the viral isolates may not be di-
rectly responsible for HIV cytopathicity and in vivo CD4 T cell
depletion may result from another mechanism.
The phenotypes of isolates from patient F correlated with the
individual's disease stage, whereas the phenotypes of isolates
from patient E did not correlate with disease stage. Hence,
NSI-SI phenotype may not always predict the clinical status or
the progression of disease in infected individuals, especially in-
fants.22 Cellular/viral factors that are intricately involved in the
viral life cycle of HIV-1 may play a larger role in the cytopathic
effects of HTV-1 regardless of the syncytium-inducing abilities
of the viruses.
The biological phenotype described in this article for pédi-
atrie NSI isolates (ability to replicate in MT-2 cells) has also
been observed with adult NSI isolates (unpublished results),
suggesting that this NSI phenotype is not restricted to the pédi-
atrie population. Vavro et al. have also reported replication in
MT-2 cells of NSI viruses from pédiatrie patients.23 Preliminary
results in MT-2 cells infected with adult and pédiatrie viral NSI
isolates indicate differences in the kinetics of virus production,
especially at early time points postinfection. Further investiga-
tion is underway to identify the factors that determine the rate
of viral replication in cells and mechanism(s) of cytopathic ef-
fect. Patient isolates such as those described in this article will
become useful tools in studies of HIV-1 induced cytopatho-
genicity.
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